CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 295,281	$ 173,016
Accounts receivable, net	87,766	94,242
Inventories	21,627	14,405
Prepaid assets	8,300	6,327
Other current assets	6,026	2,748
Total current assets	419,000	290,738
Property and equipment (net of accumulated depreciation of $80,143 and $68,809, respectively)	83,969	64,188
Operating lease right-of-use assets	47,554	26,492
Intangible assets, net	125,821	126,640
Goodwill	210,833	198,601
Restricted cash, non-current	36,030	0
Prepaid lease asset	6,084	0
Investment in non-consolidated affiliate	13,137	0
Other assets	3,057	2,847
Total assets	945,485	709,506
Current liabilities
Accounts payable	19,198	19,568
Accrued compensation	22,065	21,365
Accrued expenses and other liabilities	7,913	7,548
Short-term portion of financing obligations	4,458	5,432
Short-term portion of operating leases	4,496	3,381
Current secured debt	0	5,000
Pharma contract liability	3,570	1,610
Total current liabilities	61,700	63,904
Long-term liabilities
Convertible senior notes, net	164,544	0
Long-term debt, net	1,911	3,199
Long-term portion of operating leases	44,524	24,034
Long-term portion of term loan, net	0	91,829
Other long-term liabilities	3,155	3,566
Deferred income tax liability, net	15,422	15,566
Total long-term liabilities	229,556	138,194
Total liabilities	291,256	202,098
Stockholders' equity
Common stock, $0.001 par value, (250,000,000 shares authorized; 110,396,844 and 104,781,236 shares issued and outstanding, respectively)	110	105
Additional paid-in capital	679,235	520,278
Accumulated other comprehensive loss	43	(1,618)
Accumulated deficit	(25,159)	(11,357)
Total stockholders’ equity	654,229	507,408
Total liabilities and stockholders' equity	$ 945,485	$ 709,506